Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Investors Of Bellatrix Exploration Ltd (BXE) Go Exploring For Other Stocks

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors endured a turbulent quarter, which certainly propelled them to adjust their equity holdings so as to maintain their desired risk profile. As a result, the relevancy of these public filings and their content is indisputable, as they may reveal numerous high-potential stocks coming out of the rough quarter. The following article will discuss the smart money sentiment towards Bellatrix Exploration Ltd Ordinary Shares (Canada) (NYSEAMEX:BXE).

Bellatrix Exploration Ltd Ordinary Shares (Canada) (NYSEAMEX:BXE) was in 10 hedge funds’ portfolios at the end of September. Bellatrix Exploration investors should be aware of a decrease in enthusiasm from smart money of late. There were 12 hedge funds in our database with Bellatrix Exploration holdings at the end of the previous quarter. At the end of this article we will also compare Bellatrix Exploration to other stocks including Loxo Oncology Inc (NASDAQ:LOXO), BioDelivery Sciences International, Inc. (NASDAQ:BDSI), and Seabridge Gold, Inc. (USA) (NYSE:SA) to get a better sense of its popularity.

In the financial world there are a lot of tools shareholders have at their disposal to grade their stock investments. Two of the most innovative tools are hedge fund and insider trading activity. our experts have shown that, historically, those who follow the top picks of the top fund managers can outperform the broader indices by a very impressive amount (see the details here).

Keeping this in mind, let’s take a gander at the new action surrounding Bellatrix Exploration Ltd Ordinary Shares (Canada) (NYSEAMEX:BXE).

What have hedge funds been doing with Bellatrix Exploration Ltd Ordinary Shares (Canada) (NYSEAMEX:BXE)?

Heading into Q4, a total of 10 of the hedge funds tracked by Insider Monkey were bullish on this stock, a drop of 17% from one quarter earlier. With the smart money’s positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were upping their stakes meaningfully (or had already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Daniel Lewis’ Orange Capital has the most valuable position in Bellatrix Exploration Ltd Ordinary Shares (Canada) (NYSEAMEX:BXE), worth close to $50 million, accounting for 3.9% of its total 13F portfolio. On Orange Capital’s heels is Baupost Group, led by Seth Klarman, holding a $36.5 million position; 0.6% of its 13F portfolio is allocated to the stock. Remaining hedge funds and institutional investors that hold long positions contain Youlia Miteva’s Proxima Capital Management, David Dreman’s Dreman Value Management, and Brett Hendrickson’s Nokomis Capital.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.